SCHEMBL30164504

SCHEMBL30164504

CC(=O)NN[C@H](CC(C)C)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.64
MEN1 O00255 1/20 0.50
LMNA P02545 1/20 0.50
KMT2A Q03164 1/20 0.50
MAPT P10636 2/20 0.47
LAP3 P28838 3/20 0.45
FOLH1 Q04609 6/20 0.44
MME P08473 1/20 0.43
KDM4E B2RXH2 1/20 0.41
THRB P10828 1/20 0.41
ALOX15 P16050 1/20 0.41
NFKB1 P19838 1/20 0.41
PTGS2 P35354 1/20 0.41
THPO P40225 1/20 0.41
RECQL P46063 1/20 0.41
BLM P54132 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PLA2G2A P14555 2/20 0.40
PLA2G5 P39877 2/20 0.40
RNPEP Q9H4A4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27877720 1.00 ALDH1A1 (0.64) ALDH1A1MEN1LMNAKMT2AMAPT
Boric Acid SCHEMBL30164482 0.94 ALDH1A1 (0.58) ALDH1A1MEN1LMNAKMT2AMAPT
SCHEMBL30211920 0.84 ALDH1A1 (0.64) ALDH1A1MEN1LMNAKMT2AMAPT
SCHEMBL10762166 0.83 ALDH1A1 (0.57) ALDH1A1MEN1LMNAKMT2AMAPT
SCHEMBL2553425 0.81 ALDH1A1 (0.52) ALDH1A1MEN1LMNAKMT2AMAPT
SCHEMBL12481793 0.81 ALDH1A1 (0.52) ALDH1A1MEN1LMNAKMT2AMAPT
SCHEMBL29972290 0.80 ALDH1A1 (0.50) ALDH1A1MEN1LMNAKMT2AMAPT
SCHEMBL28204696 0.79 ALDH1A1 (0.48) ALDH1A1MEN1LMNAKMT2AMAPT
Levacetylleucine SCHEMBL9438432 0.78 ALDH1A1 (1.00) ALDH1A1MEN1LMNAKMT2AMAPT
Levacetylleucine SCHEMBL714003 0.78 ALDH1A1 (1.00) ALDH1A1MEN1LMNAKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3805237-B1 SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND JIANGSU CHUANGTE PHARMACEUTICAL TECH CO LTD (CN) 2026-01-28 EP disclosed
US-11542283-B2 Synthesis of peptide borate ester compound and use thereof JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) 2023-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11542283-B2 Synthesis of peptide borate ester compound and use thereof SEM1, VIP, PSMB11 ALDH1A1 4592/4885MEN1 139/4885LMNA 2689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.